1.53 -0.01 (-0.65%)
YMI
Stock Details
Last Trade:1.53 Change:-0.01 (-0.65%) Prev Close:1.54 Open: 1.55 Days Range:1.50 – 1.55 52 Week Range: 0.20 - 2.24 Volume:91005 P/E: N/AEPS:0.00
View AllRecent Alerts 02/10/10
Recent Alert on 01/26/10 at 8:10am
YM BioSciences (TMI) Gets OK from U.S. FDA for Two Nimotuzumab Phase II's
YM BioSciences (TMI) Gets OK from U.S. FDA for Two Nimotuzumab Phase II's
YM BioSciences Inc. (AMEX: YMI), announced that the FDA has advised the Company that it may now enroll patients at US clinical sites into two ongoing randomized, double-blind Phase II trials of its lead product, nimotuzumab. One of the two trials is... Read More
Recent Alert on 01/26/10 at 8:10am
YM BioSciences (TMI) Gets OK from U.S. FDA for Two Nimotuzumab Phase II's
YM BioSciences (TMI) Gets OK from U.S. FDA for Two Nimotuzumab Phase II's
Recent Alert on 01/12/10 at 8:00am
YM BioSciences (YMI) Receives Positive Indication from Cytopia Shareholders for M&A
YM BioSciences (YMI) Receives Positive Indication from Cytopia Shareholders for M&A
Recent Alert on 01/07/10 at 11:20am
Morning Movers 01/07: BKRS, ZIGO, EEE, SOMX, ZIXI, ONT, CITP Higher; GME, TSRA, CBK, PRXI Lower
Morning Movers 01/07: BKRS, ZIGO, EEE, SOMX, ZIXI, ONT, CITP Higher; GME, TSRA, CBK, PRXI Lower
Recent Alert on 01/07/10 at 7:53am
Roth Capital Initiates Coverage on Biotechnology and Drugs Stocks
Roth Capital Initiates Coverage on Biotechnology and Drugs Stocks
View AllRecent Press Releases
Press Release on 02/08/10 at 5:00pm
YM BioSciences reports second quarter 2010 operational and financial results
YM BioSciences reports second quarter 2010 operational and financial results
Press Release on 02/08/10 at 5:00pm
YM BioSciences reports second quarter 2010 operational and financial results
YM BioSciences reports second quarter 2010 operational and financial results
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 11/05/09 at 11:40am
Analyst upgrades, downgrades and initiations: CMCSA, GAME, GRMN, ETN, FO, MDT, MSO ...
Analyst upgrades, downgrades and initiations: CMCSA, GAME, GRMN, ETN, FO, MDT, MSO ...
Blog Posts on 09/30/09 at 7:16am
Access Pharma: MuGard, Pipeline Make for Appealing Acquisition Possibilities
Access Pharma: MuGard, Pipeline Make for Appealing Acquisition Possibilities
Blog Posts on 09/25/09 at 8:53am
BioMed News Bytes: NicOx, Allos, Pressure BioSciences, YM BioSciences
BioMed News Bytes: NicOx, Allos, Pressure BioSciences, YM BioSciences